235 related articles for article (PubMed ID: 6459296)
1. Prothionamide and prothionamide-S-oxide in experimental leprosy.
Matsuo Y; Tatsukawa H; Murray JF; Peters JH
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):302-6. PubMed ID: 6459296
[No Abstract] [Full Text] [Related]
2. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
Innami S; Leguizamón OR; Alvarenga AE
Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
[No Abstract] [Full Text] [Related]
3. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
Colin M; de Montaigne E
Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
[TBL] [Abstract][Full Text] [Related]
4. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
5. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
Pattyn SR; Portaels F; Van Loo G; Van den Breen L
Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in chemotherapy of leprosy.
Parikh DA; Maniar JK; Parikh AC; Ganapati R
J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
[No Abstract] [Full Text] [Related]
7. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
[TBL] [Abstract][Full Text] [Related]
8. Multi-drug therapy of leprosy.
Ramu G
Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
[No Abstract] [Full Text] [Related]
9. Rifampicin and isoprodian in combination in the treatment of leprosy.
Depasquale G
Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
[No Abstract] [Full Text] [Related]
10. Treatment of leprosy with rifampicin and isoprodian (L73A).
Terencio de las Aguas J
Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
[No Abstract] [Full Text] [Related]
11. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
Freerksen E
Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
[No Abstract] [Full Text] [Related]
12. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
Rohde R
Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961
[No Abstract] [Full Text] [Related]
13. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
Krenzien HN
Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
[No Abstract] [Full Text] [Related]
14. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
Aschhoff M
Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
[No Abstract] [Full Text] [Related]
15. Further data on the effect of ethionamide and prothionamide in experimental leprosy.
Pattyn SR
Lepr Rev; 1978 Sep; 49(3):199-202. PubMed ID: 692251
[No Abstract] [Full Text] [Related]
16. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
Fajardo TT; Guinto RS; Cellona RV; Abalos RM; Dela Cruz EC; Gelber RH
Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
[TBL] [Abstract][Full Text] [Related]
17. The chemotherapy of leprosy. Part 2.
Ellard GA
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319
[No Abstract] [Full Text] [Related]
18. Search for effective short-course regimens for the treatment of leprosy.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
[No Abstract] [Full Text] [Related]
19. Prospects for chemotherapy of leprosy.
Ji B
Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
[No Abstract] [Full Text] [Related]
20. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
Almeida JG
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
